Skip to main content

Advertisement

SpringerLink
Log in

Topical agents for the treatment of chronic pain

  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Unlike systemic analgesics, topical analgesics exert their analgesic activity locally and without significant systemic absorption. This is in contrast to transdermal analgesics, which require systemic absorption for clinical benefit. The mechanism of action of a particular topical analgesic is unique to the specific medication being used as a topical analgesic. Topical analgesics have been studied in an increasing number of painful clinical conditions, and the results of some of these studies are summarized in this article. The potential role of topical analgesics acting peripherally in affecting the central processing of pain as well as painful states considered to be "central," not "peripheral," also are reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Argoff CE: New analgesics for neuropathic pain: the lidocaine patch. Clin J Pain 2000, 16(suppl):S62-S65.

    PubMed  CAS  Google Scholar 

  2. Argoff CE: Topical treatments for pain. Curr Pain Headache Rep 2004, 8:261–267.

    PubMed  Google Scholar 

  3. Argoff CE: Targeted topical peripheral analgesics in the management of pain. Curr Pain Headache Rep 2002, 7:34–38.

    Google Scholar 

  4. Galer BS: Topical medications. In Bonica’s Management of Pain. Edited by Loeser JD. Philadelphia: Lippincott-Williams & Wilkins; 2001:1736–1741.

    Google Scholar 

  5. Gammaitoni AR, Alvarez NA: 24-hour application of the lidocaine patch 5% for 3 consecutive days is safe and well tolerated in healthy adult men and women [Abstract PO6.20]. Presented at the 54th Annual American Academy of Neurology Meeting. Denver: April 13–20, 2002.

  6. Argoff C, Nicholson B, Moskowitz M, et al.: Effectiveness of lidocaine patch 5% (Lidoderm®) in the treatment of low back pain. Presented at the 10th World Congress on Pain. San Diego: August 17–22, 2002.

  7. Watson CP: Topical capsaicin as an adjuvant analgesic. J Pain Symptom Manage 1994, 9:425–433.

    Article  PubMed  CAS  Google Scholar 

  8. Gammaitoni AR, Davis MW: Pharmacokinetics and tolerability of lidocaine 5% patch with extended dosing. Ann Pharmacother 2002, 36:236–240.

    Article  PubMed  CAS  Google Scholar 

  9. Ness TJ, Jones L, Smith H: Use of compounded topical analgesics-results of an Internet survey. Reg Anesth Pain Med 2002, 27:309–312.

    Article  PubMed  Google Scholar 

  10. Sawynok J: Topical and peripherally acting analgesics. Pharmacol Rev 2003, 55:1–20.

    Article  PubMed  CAS  Google Scholar 

  11. Robbins W: Clinical applications of capsaicinoids. Clin J Pain 2000, 16(suppl):S86-S89.

    Article  PubMed  CAS  Google Scholar 

  12. Bley KR: Recent developments in transient receptor potential vanilloid receptor 1 agonist based therapy. Expert Opin Investig Drugs 2004, 13:1445–1456.

    Article  PubMed  CAS  Google Scholar 

  13. Rowbotham MC: Topical analgesic agents. In Pharmacologic Approaches to the Treatment of Chronic Pain: New Concepts and Critical Issues. Edited by Fields HL Liebeskind JC. Seattle: IASP Press; 1994:211–227.

    Google Scholar 

  14. Cashman JN: The mechanism of action of NSAIDs in analgesia. Drugs 1996, 52(suppl 5):13–23.

    PubMed  CAS  Google Scholar 

  15. Yesilyurt O, Dogrul A, Gul H, et al.: Topical cannabinoid enhances topical morphine antinociception. Pain 2003, 105:303–308.

    Article  PubMed  CAS  Google Scholar 

  16. Sawynok J, Esser MJ, Reid AR: Antidepressants as analgesics: an overview of central and peripheral mechanisms of action. J Psychiatry Neurosci 2001, 26:21–29.

    PubMed  CAS  Google Scholar 

  17. Gerner P, Kao G, Srinivasa V, et al.: Topical amitriptyline in health volunteers. Reg Anesth Pain Med 2003, 28:289–293.

    Article  PubMed  CAS  Google Scholar 

  18. Physicians Desk Reference, edn 55. Montvale, NJ: Medical Economics Company; 2002.

  19. Sawynok J: Topical analgesics in neuropathic pain. Curr Pharm Des 2005, 11:2995–3004.

    Article  PubMed  CAS  Google Scholar 

  20. Rowbotham MC, Davies PS, Verkempinck, et al.: Lidocaine patch: double-blind, controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996, 65:39–44.

    Article  PubMed  CAS  Google Scholar 

  21. Galer BS, Rowbotham MC, Perander J, et al.: Topical lidocaine patch relieves post-herpetic neuralgia more effectively than vehicle patch: results of an enriched enrollment study. Pain 1999, 80:533–538.

    Article  PubMed  CAS  Google Scholar 

  22. Katz NP, Davis MW, Dworkin RH: Topical lidocaine patch produces a significant improvement in mean pain scores and pain relief in treated PHN patients: results of a multicenter, open-label trial. J Pain 2001, 2:9–18.

    Google Scholar 

  23. Meier T, Wasner G, Faust M, et al.: Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain 2003, 106:151–158.

    Article  PubMed  CAS  Google Scholar 

  24. Devers A, Galer BS: Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study. Clin J Pain 2000, 16:205–208.

    Article  PubMed  CAS  Google Scholar 

  25. Data on file. Endo Pharmaceuticals, Inc. Chadds Ford, PA.

  26. Hart-Gouleau S, Gammaitoni A, Galer BS, et al.: Openlabel study of the effectiveness and safety of the lidocaine patch 5% (Lidoderm®) in patients with painful diabetic neuropathy. Presented at the 10th World Congress on Pain. San Diego: August17–22, 2002.

  27. Galer BS, Jensen MP: Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology 1997, 48:332–338.

    PubMed  CAS  Google Scholar 

  28. Barbano RL, Herrmann DN, Hart-Gouleau S, et al.:Effectiveness, tolerability, and impact on quality of life of lidocaine patch 5% in diabetic polyneuropathy. Arch Neurol 2005, in press.

  29. Galer BS, Jensen MP, Ma T, et al.: The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the Neuropathic Pain Scale. Clin J Pain 2002, 18:297–301.

    Article  PubMed  Google Scholar 

  30. Lycka BA, Watson CP, Nevin K, et al.: EMLA® cream for the treatment of pain caused by post-herpetic neuralgia: a double-blind, placebo-controlled study [Abstract]. Proc Am Pain Soc 1996, A111.

  31. Attal N, Brasseur L, Chauvin M, et al.: Effects of single and repeated applications of a eutectic mixture of local anesthetics (EMLA®) cream on spontaneous and evoked pain in post-herpetic neuralgia. Pain 1999, 81:203–209.

    Article  PubMed  CAS  Google Scholar 

  32. Litman SJ, Vitkun SA, Poppers PJ: Use of EMLA® cream in the treatment of post-herpetic neuralgia. J Clin Anesth 1996, 8:54–57.

    Article  PubMed  CAS  Google Scholar 

  33. Lynch ME, Clark AJ, Sawynok J: A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain. Clin J Pain 2003, 19:323–328.

    Article  PubMed  CAS  Google Scholar 

  34. Quan D, Wellish M, Gilden DH: Topical ketamine treatment of postherpetic neuralgia. Neurology 2003, 60:1391–1392.

    PubMed  Google Scholar 

  35. Greenway FL, Frome BM, Engels TM, et al.: Temporary relief of postherpetic neuralgia pain with topical geranium oil. Am J Med 2003, 115:586–587.

    Article  PubMed  Google Scholar 

  36. Rains C, Bryson HM: Topical capsaicin: a review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy, and osteoarthritis. Drugs Aging 1995, 7:317–328.

    PubMed  CAS  Google Scholar 

  37. Robbins WR, Staats PS, Levine J, et al.: Treatment of intractable pain with topical large-dose capsaicin: preliminary report. Anesth Analg 1998, 86:579–583.

    Article  PubMed  CAS  Google Scholar 

  38. Backonja M, Malan P, Brady S, et al.: One-hour high concentration trans-capsaicin applications provide durable pain relief in initial and repeat treatment of postherpetic neuralgia. Presented at the Annual Scientific Meeting of the American Academy of Neurology. San Francisco: April 24–May 1, 2004.

  39. Simpson D, Brown S, Sampson J, et al.: A single application of high-concentration trans-capsaicin leads to 12 weeks of pain relief in HIV-associated distal symmetrical polyneuropathy: results of an open label trial. Presented at the Annual Scientific Meeting of the American Academy of Neurology. San Francisco: April 24–May 1, 2004.

  40. Mason L, Moore RA, Derry S, et al.: Systematic review of topical capsaicin for the treatment of chronic pain. BMJ 2004, 328:991–996.

    Article  PubMed  CAS  Google Scholar 

  41. McCleane G: Topical application of doxepin hydrochloride, capsaicin, and a combination of both produces analgesia in chronic neuropathic pain: a randomized, double-blind, placebo-controlled study. Br J Clin Pharmacol 2000, 49:574–579.This study points to the potential for tricyclic antidepressants to be effective as a topical analgesic. Not only may this be better tolerated than a systemically administered tricyclic, this highlights the multiple mechanisms of action that tricyclic antidepressants may possess.

    Article  PubMed  CAS  Google Scholar 

  42. Lynch ME, Clark AJ, Sawynok J, et al.: Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial. Anesthesiology 2005, 103:140–146.This study points to the potential for tricyclic antidepressants to be effective as a topical analgesic. Not only may this be better tolerated than a systemically administered tricyclic, this highlights the multiple mechanism of actions that tricyclic antidepressants may possess.

    Article  PubMed  CAS  Google Scholar 

  43. Lynch ME, Clark AJ, Sawynok J, et al.: Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study. J Pain 2005, 6:644–649.This study points to the potential for tricyclic antidepressants to be effective as a topical analgesic. Not only may this be better tolerated than a systemically administered tricyclic, this highlights the multiple mechanism of actions that tricyclic antidepressants may possess.

    Article  PubMed  CAS  Google Scholar 

  44. Mazieres B, Rouanet S, Velicy J, et al.: Topical ketoprofen patch (100 mg) for the treatment of ankle sprain: a randomized, double-blind, placebo-controlled study. Am J Sports Med 2005, 33:515–523.

    Article  PubMed  Google Scholar 

  45. Mazieres B, Rouanet S, Guillon Y, et al.: Topical ketoprofen patch in the treatment of tendonitis: a randomized, double blind, placebo-controlled study. J Rheumatol 2005, 32:1563–1570.

    PubMed  CAS  Google Scholar 

  46. Predel HG, Koll R, Pabst H, et al.: Diclofenac patch for topical treatment of acute impact injuries: a randomized, double-blind, placebo-controlled, multicenter study. Br J Sports Med 2004, 38:318–323.

    Article  PubMed  CAS  Google Scholar 

  47. Marten M: Efficacy and tolerability of a topical NSAID patch (local action transcutaneous fiurbiprofen) and oral diclofenac in the treatment of soft-tissue rheumatism. Clin Rheumatol 1997, 16:25–31.

    Article  Google Scholar 

  48. Galer BS, Rowbotham MC, Perander J, et al.: Topical diclofenac patch significantly reduces pain associated with minor sports injuries: results of a randomized, double-blind, placebo-controlled, multicenter study. J Pain Symptom Manage 2000, 19:287–294.

    Article  PubMed  CAS  Google Scholar 

  49. Jenoure P, Segesser B, Luhti U, et al.: A trial with diclofenac HEP plaster as topical treatment in minor sports injuries. Drugs Exp Clin Res 1993, 19:125–131.

    PubMed  CAS  Google Scholar 

  50. Campbell J, Dunn T: Evaluation of topical ibuprofen cream in the treatment of acute ankle sprains. J Accidental Emerg Med 1994, 11:178–182.

    Article  CAS  Google Scholar 

  51. Airaksinen O, Venalainen J, Pietilainen T: Ketoprofen 2.5% gel versus placebo gel in the treatment of acute soft tissue injuries. Int J Clin Pharmacol Ther Toxicol 1993, 31:561–563.

    PubMed  CAS  Google Scholar 

  52. Machen J, Whitefield M: Efficacy of a proprietary ibuprofen gel in soft tissue injuries: a randomized, double-blind, placebo-controlled stud)y. Intl J Clin Prac 2002, 56:102–106.

    CAS  Google Scholar 

  53. Whitefield M, O’Kane CJ, Anderson S: Comparative efficacy of a proprietary topical ibuprofen gel and oral ibuprofen in acute soft tissue injuries: a randomized, double-blind study. J Clin Pharm Ther 2002, 27:409–417.

    Article  PubMed  CAS  Google Scholar 

  54. Bruhlmann P, Michel BA: Topical diclofenac patch in patients with knee osteoarthritis: a randomized, doubleblind, controlled clinical trial. Clin Exp Rheumatol 2003, 21:193–198.

    PubMed  CAS  Google Scholar 

  55. Tugwell PS, Wells GA, Shainhouse JZ: Equivalence study of a topical diclofenac solution (pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized, controlled trial. J Rheumtol 2004, 31:2002–2012.

    CAS  Google Scholar 

  56. Di Rienzo BL, Di Rienzo BA, D’Emilia E, et al.: Topical versus systemic diclofenac in the treatment of temporo-mandibular joint dysfunction symptoms. Acta Otorhinolaryngol Ital 2004, 24:279–283.

    Google Scholar 

  57. Lin J, Zhang W, Jones A, et al.: Efficacy of topical nonsteroidal anti-infiammatory drugs in the treatment of osteoarthritis: meta-analysis of randomized, controlled trials. BMJ 2004, 329:324–328.

    Article  PubMed  CAS  Google Scholar 

  58. Mason L, Moore RA, Edwards JE, et al.: Topical NSAIDS for chronic musculoskeletal pain: a systematic review and meta-analysis. BMC Musculoskelet Disord 2004, 5:28.This review is particularly timely given the concerns regarding all of the types of nonsteroidal anti-infiammatory medications.

    Article  PubMed  CAS  Google Scholar 

  59. Mason L, Moore RA, Edwards JE, et al.: Systematic review of topical rubefacients containing salicylates for the treatment of acute and chronic pain. BMJ 2004, 328:995.

    Article  PubMed  CAS  Google Scholar 

  60. Ottillinger B, Gomor B, Michel BA, et al.: Efficacy and safety of eltenac gel in the treatment of knee osteoarthritis. Osteoarthritis Cartilage 2001, 9:273–280.

    Article  PubMed  CAS  Google Scholar 

  61. Sandelin J, Harilainen A, Crone H, et al.: Local NSAID gel (eltenac) in the treatment of osteoarthritis of the knee: a double-blind study comparing eltenac with oral diclofenac and placebo gel. Scand J Rheumatol 1997, 26:287–292.

    Article  PubMed  CAS  Google Scholar 

  62. Dreiser RL, Tisne-Camus M: DHEP plasters as a topical treatment of knee osteoarthritis: a double-blind, placebo-controlled study. Drugs Exp Clin Res 1993, 19:107–115.

    Google Scholar 

  63. Galeazzi M, Marcolongo R: A placebo-controlled study of the efficacy and tolerability of a nonsteroidal anti-infiammatory drug, DHEP plaster in infiammatory peri- and extra-articular rheumatological diseases. Drugs Exp Clin Res 1993, 19:107–115.

    PubMed  CAS  Google Scholar 

  64. Gallachia G, Marcolongo R: Pharmacokinetics of diclofenac hydroxyethylpyrrolidine (DHEP) plasters in patients with monolateral knee joint effusion. Drugs Exp Clin Res 1993, 19:95–97.

    Google Scholar 

  65. Winocur E, Gavish A, Halachmi M, et al.: Topical application of capsaicin for the treatment of localized pain in the temporomandibular joint area. J Orofac Pain 2000, 14:31–36.

    PubMed  CAS  Google Scholar 

  66. Cohen M, Wolfe R, Mai T, et al.: A randomized, doubleblind, placebo-controlled trial of a topical crème containing glucosamine sulfate, chondroitin sulfate, and camphor for osteoarthritis of the knee. J Rheumatol 2003, 30:523–528.

    PubMed  CAS  Google Scholar 

  67. Keitel W, Frerick H, Kuhn U, et al.: Capsicum pain plaster in chronic non-specific low back pain. Arzneimittelforschung 2001, 51:896–903.

    PubMed  CAS  Google Scholar 

  68. Lipman AG, Dalpiaz AS, London SP: Topical lidocaine patch therapy for myofascial pain [Abstract 782]. Presented at the Annual Scientific Meeting of the American Pain Society. Baltimore: March 14–17, 2002.

  69. Briggs M, Nelson EA: Topical agents or dressings for pain in venous leg ulcers. Cochrane Database Syst Rev 2003, 1:CD001177,

    PubMed  Google Scholar 

  70. Flock P: Pilot study to determine the effectiveness of diamorphine gel to control pressure ulcer pain. J Pain Symptom Manage 2003, 25:547–554.

    Article  PubMed  CAS  Google Scholar 

  71. Zeppetella G, Ribeiro PJ: Analgesic efficacy of morphine applied topically to painful ulcers. J Pain Symptom Manage 2003, 25:555–558.

    Article  PubMed  CAS  Google Scholar 

  72. Gallagher RE, Arndt DR, Hunt KL: Analgesic effects of topical methadone: a report of four cases. Clin J Pain 2005, 21:190–192.

    Article  PubMed  Google Scholar 

  73. Vernassiere C, Cornet C, Trechot P, et al.: Study to determine the efficacy of topical morphine on painful chronic skin ulcers. J Wound Care 2005, 14:289–293.

    PubMed  CAS  Google Scholar 

  74. Cerchietti LC, Navigante AH, Bonomi MR, et al.: Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma. Cancer 2002, 95:2230–2236.

    Article  PubMed  CAS  Google Scholar 

  75. Slatkin NE, Rhiner M: Topical ketamine in the treatment of mucositis pain. Pain Med 2003, 4:298–303.

    Article  PubMed  Google Scholar 

  76. Watterson G, Howard R, Goldman A: Peripheral opiates in infiammatory pain. Arch Dis Child 2004, 89:679–681.

    Article  PubMed  CAS  Google Scholar 

  77. Galeotti N, De Cesare Mannelli L, Mazzanti G, et al.: Menthol: a natural analgesic compound. Neurosci Lett 2002, 322:145–148.

    Article  PubMed  CAS  Google Scholar 

  78. Sandroni P: Central neuropathic itch: A new treatment option? Neurology 2002, 59:778–779.

    PubMed  Google Scholar 

  79. Lockhart E: Topical combination of amitriptyline and ketamine for post herpetic neuralgia. J Pain 2004, 1(suppl):82.

    Article  Google Scholar 

  80. Bernstein J, Phillips S, Group T: A new topical medication for the adjunctive relief of painful diabetic neuropathy and postherpetic neuralgia. J Pain 2004, 1(suppl):82.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cohn Pain Management Center, North Shore University Hospital/NYU School of Medicine, 4300 Hempstead Turnpike, 11714, Bethpage, NY, USA

    Charles E. Argoff MD

Authors
  1. Charles E. Argoff MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Charles E. Argoff MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Argoff, C.E. Topical agents for the treatment of chronic pain. Current Science Inc 10, 11–19 (2006). https://doi.org/10.1007/s11916-006-0004-4

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-006-0004-4

Keywords

Search

Navigation